Eyal Grunebaum, University of Calgary

Research

Adenine Base Editing Gene Editing Gene Therapy Clinical Trial Inborn Errors Of Immunity Rare Diseases Severe Combined Immune Deficiency

Latest funding

A pilot project to demonstrate feasibility of a Canadian gene therapy clinical trials platform for rare genetic diseases: Gene Therapy for CD3delta Severe Combined Immune Deficiency.
CIHR · 2022 · Principal investigator
$606,576
A pilot project to demonstrate feasibility of a Canadian gene therapy clinical trials platform for rare genetic diseases: Gene Therapy for CD3delta Severe Combined Immune Deficiency.
CIHR · 2022 · Principal investigator
$2,426,302
Primary EBV Infection in the Immunosuppressed Setting of Organ Transplantation: Determinants of the Outcomes of Virus-Host Interaction
CIHR · 2009 · Co-investigator
$509,125

All 3 grants and awards

A pilot project to demonstrate feasibility of a Canadian gene therapy clinical trials platform for rare genetic diseases: Gene Therapy for CD3delta Severe Combined Immune Deficiency.

Principal investigatorCIHR2022Operating Grant: Clinical Trials Projects - Indirect Costs

Principal investigators: Wright, Nicola A; Cuvelier, Geoff; Grunebaum, Eyal; Guilcher, Greg; Kohn, Donald B; Lewis, Victor; Marwaha, Ashish K; Murguia-Favela, Luis E; Narendran, Aru; Prokopishyn, Nicole L; Romero Garcia, Zulema; Suresh, Sneha

Keywords: Adenine Base Editing; Gene Editing; Gene Therapy Clinical Trial; Inborn Errors Of Immunity; Rare Diseases; Severe Combined Immune Deficiency

$606,576

A pilot project to demonstrate feasibility of a Canadian gene therapy clinical trials platform for rare genetic diseases: Gene Therapy for CD3delta Severe Combined Immune Deficiency.

Principal investigatorCIHR2022Operating Grant: Clinical Trials Projects

Principal investigators: Wright, Nicola A; Cuvelier, Geoff; Grunebaum, Eyal; Guilcher, Greg; Kohn, Donald B; Lewis, Victor; Marwaha, Ashish K; Murguia-Favela, Luis E; Narendran, Aru; Prokopishyn, Nicole L; Romero Garcia, Zulema; Suresh, Sneha

Keywords: Adenine Base Editing; Gene Editing; Gene Therapy Clinical Trial; Inborn Errors Of Immunity; Rare Diseases; Severe Combined Immune Deficiency

$2,426,302

Primary EBV Infection in the Immunosuppressed Setting of Organ Transplantation: Determinants of the Outcomes of Virus-Host Interaction

Co-investigatorCIHR2009Operating Grant

Principal investigators: Allen, Upton D; Beyene, Joseph

Keywords: Epstein-Barr Virus; Gene Expression; Lymphoproliferation Posttransplant; Microarray; Rt-Pcr; Single Nucleotide Polymorphisms

$509,125

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2022

Subject: Prospective PhD student: Adenine Base Editing Dear Professor Grunebaum, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on adenine base editing connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "A pilot project to demonstrate feasibility of a Canadian gene therapy clinical trials platform for rare genetic diseases: Gene Therapy for CD3delta Severe Combined Immune Deficiency." (2022), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]